The Canadian Biosimilars Forum commends the Government of British Columbia for taking a decisive step toward enhancing patient care by implementing a one-time transition of patients currently using a reference biologic to a biosimilar in consultation with their doctors, expanding treatment options for patients and their physicians across the province.
The Canadian Biosimilars Forum
The arrival and introduction of biosimilars is helping change access to medicines and is currently impacting patients, health care providers and policymakers across Canada. These new drugs represent an enormous opportunity to expand and enhance patient care and improve the sustainability of Canadian health care.
The Canadian Biosimilars Forum is an alliance of companies who represent the breadth of the biosimilars industry and who are collectively working to increase awareness, access and adoption of biosimilars across Canada.
Biosimilars can play a significant role in the health care system.